ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,214.08
0.51%
US Tech 100
17,712.80
0.41%
Dow Jones
39,387.76
0.00%
Brent Oil
84.165
0.26%
Bitcoin
63,388.46
0.54%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/10/20248:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:COLLCollegium Pharmaceutical Inc
05/10/20248:02AMGlobeNewswire Inc.Telos Corporation Announces First Quarter Results Above Guidance: Reports $29.6 Million of Revenue, 37.0% GAAP Gross Margin, and 42.2% Cash Gross MarginNASDAQ:TLSTelos Corporation
05/10/20248:01AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:BRXBrixmor Property Group Inc
05/10/20248:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALTIAITi Global Inc
05/10/20248:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
05/10/20248:01AMEdgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:VRTXVertex Pharmaceuticals Inc
05/10/20248:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLSTelos Corporation
05/10/20248:01AMPR Newswire (US)Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Sign a Collaboration Agreement to Conduct a Phase 2 Randomized, Clinical Trial in Early-Stage Breast Cancer in Europe for INT230-6, Intensity's Lead Drug CandidateNASDAQ:INTSIntesity Therapeutics Inc
05/10/20248:01AMPR Newswire (US)Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient PlasmaNASDAQ:AEMDAethlon Medical Inc
05/10/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:CHTChunghwa Telecom Co Ltd
05/10/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PDCOPatterson Companies Inc
05/10/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:GENCGencor Industries Inc
05/10/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:VSOGFVista Oil and Gas SAB de CV (PK)
05/10/20248:00AMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:FRMEPFirst Merchants Corporation
05/10/20248:00AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:THMInternational Tower Hill Mines Ltd New
05/10/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:VCXB10X Capital Venture Acquisition Corp III
05/10/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:YETIYETI Holdings Inc
05/10/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DGHIDigihost Technology Inc
05/10/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RDVTRed Violet Inc
05/10/20248:00AMInvestorsHub NewsWireAvant Technologies Equipping AI-Managed Data Center with High Performance Computing SystemsUSOTC:AVAIAvant Technologies Inc (QB)
05/10/20248:00AMBusiness WireSunOpta Inc. to Participate in Upcoming Investor ConferencesNASDAQ:STKLSunOpta Inc
05/10/20248:00AMBusiness WireNotice of Greylock McKinnon Associates, Inc. Data Breach
05/10/20248:00AMGlobeNewswire Inc.UPCX to Host AMA with CMO Mr. Sato on Wallet Testnet and Milestones
05/10/20248:00AMGlobeNewswire Inc.Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILDNASDAQ:LQDALiquidia Corporation
05/10/20248:00AMBusiness WireSugarCRM Named 2024 CRM Excellence Award Winner for the Fourth Year Running
05/10/20248:00AMBusiness WireWisdomTree Reports Monthly Metrics for April 2024NYSE:WTWisdomTree Inc
05/10/20248:00AMBusiness WireViking Announces New Vice President of Investor RelationsNYSE:VIKViking Holdings Ltd
05/10/20248:00AMBusiness WireCBL Properties Reports Strong Results for First Quarter 2024NYSE:CBLCBL and Associates Properties Inc
05/10/20248:00AMGlobeNewswire Inc.Doman Building Materials Group Ltd. Announces Meeting Results for Election of DirectorsTSX:DBMDoman Building Materials Group Ltd
05/10/20248:00AMBusiness WireSunOpta Inc. to Participate in Upcoming Investor ConferencesTSX:SOYSunOpta Inc

Your Recent History

USOTC
EMGE
Emergent Health (PK)
USOTC
TXTM
ProText Mobility (PK)
USOTC
SONG
Music Licensing (PK)
USOTC
SHMP
NaturalShrimp (QB)
USOTC
GNCP
GNCC Capital (CE)
USOTC
RDAR
Raadr (PK)
NASDAQ
RNAZ
TransCode Therapeutics
USOTC
RONN
Ronn Motor (PK)
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
CLNV
Clean Vision (QB)
USOTC
YCRM
Yuenglings Ice Cream (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
IPIX
Innovation Pharmaceuticals (CE)
USOTC
ERHE
ERHC Energy (CE)
USOTC
GSTC
Globestar Therapeutics (PK)
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved